Search - tctmd.com

Displaying 41 - 60 of 238

Sort: Relevancy | Date

News Conference News ESOC 2024

More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis

Todd Neale

May 21, 2024

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

News Daily News

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

L.A. McKeown

February 29, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

News Daily News

Slight Shift Seen After Calories Added to Fast-food Menus

L.A. McKeown

December 15, 2023

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Daily News

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Michael O'Riordan

May 01, 2023

Advertisement

More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

January 2024 Dispatch for the CV Team

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Slight Shift Seen After Calories Added to Fast-food Menus

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

What’s Going to Be Hot at ESC 2023?

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content